Genitourinary System Carcinoma — Trials

Genitourinary System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

4,916 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,498
Recruiting: 782
Ph III recruiting: 85
Growth YoY: +17.8%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (758)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07583160	YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer(YS247)	enrolling by invitation	Phase 1	18	Changhai HospitalOTHER	1	May 13, 2026	clinicaltrials
NCT07353294	Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC	enrolling by invitation	Phase 1	12	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER	1	Apr 22, 2026